Walmart shares gained Monday as several Wall Street analysts bumped up price targets, putting attention on the retailer ahead of its fiscal first-quarter earnings later this week.
The Dow Jones Industrial Average rose on Monday, breaking away from softer trading in the S&P 500 and Nasdaq, as an easing in U.S. Treasury yields gave blue-chip shares a small bid after last week’s bond-driven selloff.
Stocks were mixed in late morning trade Monday. The Dow rose, but the S&P 500 and Nasdaq edged lower. Treasury yields pulled back, but that wasn’t enough to offset all of the pressure from last week’s rout tied to the bond market.
Intel stock picked up some ground in early New York trading Monday after chip names tumbled last week. Traders looked at fresh analyst targets, remarks from President Donald Trump on the government holding, and more arguments about how much is left in the AI trade.
Salesforce was restarted at Underperform by BofA Securities, with the analyst setting a $160 target on the stock. BofA said the company is staring down a “structural reset” as AI shifts customer buying and usage. Despite that, shares rose in early Monday trade, gaining $3.36 to $176.87.
Vanguard Total Stock Market ETF pulled in $852.57 million of net inflows over five days, TipRanks’ automated newsdesk reported. The ETF slipped 0.24% for the week. Net inflows track new money in minus any withdrawn.
Oil prices fell and stocks steadied on Monday after reports that Washington may offer Iran a temporary sanctions waiver, giving markets a thin reason to price in progress toward reopening the Strait of Hormuz. The move reversed an earlier risk-off trade sparked by drone attacks in the Gulf and a fresh jump in crude.
Bank of America is sticking with its Buy on Alphabet and holds its $430 target, with the focus turning to Tuesday’s Google I/O. Analyst Justin Post thinks the developer event will bring a raft of AI updates—Gemini tweaks, tighter integration, new agent features. He said the stock may need some “AI surprises” for further multiple expansion.
Quince Therapeutics Inc. shares headed into Monday’s session under fresh scrutiny after a late-Friday ownership filing added another data point to a stock already being driven less by drug-development news than by restructuring, Nasdaq compliance and cash runway.
Macy’s stock looked set to open higher Monday after Berkshire Hathaway revealed a new position in the company. The department-store stock had been down for the year until the filing.
Virax Biolabs Group Limited shares were indicated sharply higher before the Nasdaq open on Monday, adding to a gain at Friday’s close, after the microcap diagnostics company appeared in a weekend sponsored television segment and a fresh ownership filing hit the tape.
Hims & Hers Health shares dropped ahead of Monday’s open. The telehealth company said it wants to raise $300 million with convertible senior notes, a kind of debt that could switch into cash, equity, or a mix of both.
Huachen AI Parking Management Technology Holding Co. shares jumped sharply in premarket trading in the U.S. on Monday. The move sent the little Nasdaq-listed Chinese company's stock higher ahead of the open.
HIVE Digital Technologies Ltd. surged in U.S. pre-market trading Monday after BUZZ HPC, its unit, announced a 320 MW AI infrastructure project set for the Greater Toronto Area. The former bitcoin miner is looking to reposition itself as a data center company.
World Investment Advisors picked up a new stake in Bloom Energy, adding to the list of firms buying into the San Jose fuel-cell maker as money flows into power names tied to AI data centers. The firm purchased 12,795 shares worth roughly $1.1 million in the fourth quarter, according to a filing summary.
Baidu shares gained pre-market in New York on Monday as the Chinese search and AI group topped quarterly revenue estimates. A jump in AI cloud sales made up for continued softness in advertising, according to the company.
Redwire Corp traded flat ahead of the U.S. open Monday, sticking close to Friday's finish after climbing in each of the last five sessions. Investors were watching a defense tech event in Florida for direction on the space and drone company’s recent run. Shares last showed at $14.06, barely above the previous close, in premarket quotes on the New York Stock Exchange.
Regeneron Pharmaceuticals shares dropped 11.8% in premarket trading Monday after its late-stage melanoma drug combo failed to meet its main goal. The move drew notice as Nasdaq futures pointed lower. Reuters singled out the decline before the bell, as premarket trading often moves on thin volume.
Stocks futures dropped Monday with crude staying close to $110 and Treasury yields moving higher, putting pressure on traders to look at “top stocks to buy today” more carefully. The focus is now on which companies can still produce demand as borrowing and energy get pricier.
Sunshine Biopharma shares pointed higher in premarket Monday, bouncing after a selloff Friday. Traders looked at a new $6 million share-and-warrant registration and noted the latest quarterly loss.
July 10, 2026, 3:56 AM EDT. The fair value estimate for CMC Markets (LSE:CMCX) jumped to £6.30 a share from £4.47 as new growth and cost control forecasts came in higher. Jefferies and Panmure Liberum raised their ratings to Buy, with price targets up to 700 GBp (£7.00). Both cited a better view on operating income and early signs from new revenue partnerships and services. Jefferies pointed to clearer timelines. Still, the analysts only recently moved their ratings up from Hold, showing there are still worries over execution and cost control. Revenue growth outlook was increased to 16.39% from 11.24%. Net margin forecast was also raised, now at 25.97%. Cost and delivery of partnerships remain things to watch.